HIPAA-era identity controls are lagging behind healthcare sprawl

At a glance

What this is: This is an Imprivata commentary on how healthcare digitisation and shared access are widening HIPAA risk and exposing gaps in identity and access governance.

Why it matters: It matters because healthcare teams must secure human users, devices, and third-party access at the same time, while preserving clinical speed and reducing compliance and privacy exposure.

By the numbers:

• 90% of IT leaders say properly managing NHIs is essential for a successful zero-trust implementation.
• 92% of organisations expose NHIs to third parties, raising concerns about supply chain security.
• Only 5.7% of organisations have full visibility into their service accounts.
• 79% of organisations have experienced secrets leaks, with 77% of these incidents resulting in tangible damage.

👉 Read Imprivata's commentary on HIPAA, shared devices, and vendor access

Context

Healthcare identity governance now spans clinicians, shared devices, contractors, and the service accounts and credentials that connect clinical systems. HIPAA still applies to the same privacy problem it always did, but the operating environment is far more distributed, with more endpoints, more vendors, and more opportunities for access to drift beyond intended use.

That means the real challenge is not simply stronger login controls. It is sustaining patient privacy and patient safety across a mixed identity estate where human access, device access, and third-party access all have to be governed with consistent visibility, revocation, and monitoring.

Key questions

Q: How should healthcare organisations govern shared mobile devices without slowing clinicians down?

A: Healthcare organisations should use session-level access controls, fast authentication, and strong user attribution so shared devices do not erase accountability. The goal is not to make clinicians wait, but to preserve a reliable identity trail for every patient-data access event. That is what supports both workflow speed and HIPAA defensibility.

Q: Why do third-party access relationships create HIPAA risk?

A: Third-party access becomes risky when vendor or contractor credentials stay active longer than the business need that justified them. Healthcare environments often grant access for integration or support, then fail to revoke it cleanly when roles change. That leaves patient data exposed through identities that are still trusted but no longer necessary.

Q: How do security teams know whether zero trust is working in healthcare?

A: Zero trust is working when access decisions depend on current identity, device posture, and session context rather than on network location. If staff can reach sensitive systems simply because they are inside the hospital environment, the model has not shifted trust to the right control points. Continuous evaluation is the signal that matters.

Q: Who is accountable when shared access exposes patient data?

A: Accountability sits with the organisation that approves, monitors, and revokes the access path, not just with the person who used it. In healthcare, that usually means identity, security, privacy, and clinical operations must share governance over shared devices and third-party credentials. HIPAA does not remove that accountability chain.

Technical breakdown

Shared mobile devices and clinical access control

Shared-use devices compress multiple users into a small number of endpoints, so identity assurance must move from device ownership to session-level control. In healthcare, that means fast authentication, strong session isolation, and reliable user attribution after sign-in. If the device is shared but the identity trail is not, investigators cannot tell who accessed what, when, or under which role. That creates both privacy risk and audit weakness, especially where clinicians move quickly between tasks and locations.

Practical implication: enforce per-session access controls and audit trails on shared devices so user attribution survives rapid handoff between clinicians.

Vendor access, third parties, and HIPAA governance

Healthcare vendors often sit inside the same trust boundary as employees, but they rarely receive the same lifecycle discipline. That is where credential sprawl, stale access, and overprivilege become compliance problems, not just security problems. Under HIPAA, the issue is not only whether a third party can connect, but whether its access is still necessary, monitored, and revocable when the relationship changes. Continuous governance matters more than one-time approval.

Practical implication: treat third-party credentials as governed identities with expiry, review, and offboarding requirements, not as permanent operational exceptions.

Zero Trust network access for clinical environments

Zero Trust Network Access shifts trust from the network to the identity, device, and context of each session. In healthcare, that is useful because staff work across wards, clinics, home settings, and contractor-managed services, often using different devices and connection paths. The model only works if access decisions are continuously evaluated and tied to real-time posture, not assumed because someone is inside the hospital network. Without that, ZTNA becomes a front door rather than a control plane.

Practical implication: link access decisions to identity, device posture, and session context so network location does not become a substitute for authorisation.

Threat narrative

Attacker objective: The objective is to reach protected patient data or clinical systems through identities and endpoints that are trusted operationally but not governed tightly enough.

1. Entry occurs through expanded healthcare access surfaces, including shared devices, vendor connections, and distributed clinical endpoints that broaden who can reach patient systems.
2. Escalation follows when weak credential management and limited real-time tracking let access persist beyond the user, device, or vendor relationship that originally justified it.
3. Impact appears as privacy exposure, insider-threat opportunities, compliance reporting gaps, and HIPAA penalties when access cannot be attributed, contained, or revoked cleanly.

Breaches seen in the wild

• IOS app secrets leakage report — iOS apps leaking hardcoded secrets and credentials endangering user privacy.
• MongoBleed breach — MongoBleed exposed secrets across 87K MongoDB servers.

Read our 52 NHI Breaches Analysis report for a comprehensive view of breaches impacting Non-Human Identities including AI Agents.

NHI Mgmt Group analysis

Healthcare identity sprawl is now a governance problem, not just an operational convenience issue. Shared-use devices, vendor access, and distributed care environments create an identity estate that is wider than the old employee-login model. HIPAA still governs privacy, but the control surface now includes every credential, endpoint, and third-party relationship that can touch patient data. The practitioner implication is that access governance must follow the workflow, not the office network.

Third-party access without lifecycle offboarding: Healthcare ecosystems often keep vendor and contractor access alive long after the business need has changed. That assumption was designed for stable, slow-moving internal access relationships. It fails when vendors, outsourced services, and temporary clinical integrations can outlive the period for which they were approved. The implication is that revocation, not just approval, must be treated as a first-class governance event.

Shared devices expose the weakest point in traditional identity assurance. Healthcare teams may know who owns the device fleet, but not always which user touched which application session under pressure. That makes attribution, post-incident review, and HIPAA audit response harder than in single-user environments. The practitioner implication is that identity controls need to preserve session-level accountability even when devices are intentionally communal.

Zero Trust only helps healthcare if it is applied as an identity decision model, not a perimeter replacement. In clinical environments, network presence says little about trustworthiness because users, devices, and vendors all move continuously across contexts. That means contextual authorisation and continuous verification are the real controls, while static network trust is the failure mode. The practitioner implication is to make access decisions conditional on current identity, device, and session state.

Patient privacy monitoring is the named concept that healthcare teams should operationalise now. Privacy monitoring here means tracking who accessed patient information, from which device or session, and whether that access still matched the approved clinical or vendor purpose. Without that visibility, HIPAA becomes reactive after the fact instead of preventive during the session. The practitioner implication is to make monitoring and revocation part of the same control plane.

From our research:

• 90% of IT leaders say properly managing NHIs is essential for a successful zero-trust implementation, according to the Ultimate Guide to NHIs.
• 79% of organisations have experienced secrets leaks, with 77% of these incidents resulting in tangible damage.
• For a broader governance lens, see the 52 NHI breaches Report for real-world patterns that show how access scope and lifecycle failures become incidents.

What this signals

Identity governance in healthcare is becoming a multi-actor control problem. The same programme now has to handle clinicians, shared devices, contractors, and the machine identities that keep clinical integrations running. When access is distributed this widely, the winning control is not a stronger login alone but a governance model that can track, review, and revoke trust across the full care pathway.

Patient privacy monitoring is emerging as the operational bridge between compliance and security. In practice, that means knowing who touched patient data, from which endpoint, under which session, and whether the access still matched the original purpose. Without that chain, incident response and HIPAA reporting both start from incomplete evidence.

Healthcare teams should expect vendor and shared-device risk to keep rising as care delivery becomes more mobile and more interdependent. The programme response is to tighten identity lifecycle discipline, use context-aware access decisions, and make offboarding as visible as onboarding. That is the only way to keep workflow efficiency from outpacing control.

For practitioners

• Map shared-device identity paths Trace which clinicians, contractors, and support staff use each shared mobile device, then require session-level attribution for every patient-data access event. Preserve the audit trail across handoff points so investigations can reconstruct who did what under clinical pressure.
• Time-box vendor and contractor credentials Assign expiry, review, and offboarding checkpoints to every third-party account that can reach patient systems. Remove access when the clinical service, device relationship, or contract no longer justifies it, instead of relying on informal renewal.
• Tie access to current device context Require device posture and session context to be evaluated at sign-in and during sensitive operations, especially for mobile clinical access. Do not let network location or hospital presence substitute for current authorisation.
• Build privacy monitoring into clinical workflows Monitor patient-data access in the same workflow where care delivery happens, so unusual access is visible before the session closes. Make escalation paths clear for privacy teams, security teams, and clinical managers.

Key takeaways

• Healthcare identity risk now spans clinicians, shared devices, vendors, and the credentials that connect them, so HIPAA governance has to cover the whole access chain.
• The practical failure mode is not just weak authentication, but poor attribution and slow revocation when access outlives the business need.
• Identity and access teams should treat privacy monitoring, Zero Trust, and offboarding as linked controls, because patient safety depends on all three working together.

Key terms

• Shared-use device: A shared-use device is an endpoint used by multiple people across different sessions, such as a workstation or mobile device in a clinical setting. Security depends on preserving user attribution, session isolation, and auditability, because the device itself no longer proves who accessed patient data.
• Patient privacy monitoring: Patient privacy monitoring is the ongoing tracking of who accessed patient information, from which system or session, and whether that access matched the approved purpose. It turns privacy from a retrospective compliance exercise into an operational control that can support detection, investigation, and revocation.
• Vendor access lifecycle: Vendor access lifecycle is the full set of controls that govern third-party identities from approval through review, expiry, and offboarding. In healthcare, it matters because contractor and supplier access can outlive the service need, leaving sensitive systems exposed through trusted but stale credentials.
• Zero Trust Network Access: Zero Trust Network Access is an access model that grants entry based on current identity and context rather than on network location. In healthcare, it is useful only when the decision is continuously evaluated against device posture, session state, and business purpose.

Deepen your knowledge

NHI governance, agentic AI identity, and machine identity lifecycle are core topics in our NHI Foundation Level course, the industry's only accredited NHI security programme. If you are responsible for identity security strategy or NHI governance in your organisation, it is worth exploring.

This post draws on content published by Imprivata: Thoughts from Dr. Sean Kelly on HIPAA’s 29th Anniversary. Read the original.